Work

IKZF1 expression is a prognostic marker in newly diagnosed standard-risk multiple myeloma treated with lenalidomide and intensive chemotherapy: a study of the German Myeloma Study Group (DSMM)

Year: 2016

Type: article

Source: Leukemia

DOI: 10.1038/leu.2016.384

Authors: J Krönke, F Kuchenbauer, M Kull, V Teleanu, L Bullinger, D Bunjes, A Greiner, S Kolmus, S Köpff, M Schreder, L-O Mügge, C Straka, M Engelhardt, H Döhner, H Einsele, F Bassermann, R Bargou, S Knop, C Langer

Institutions: University Hospital Ulm, Universitätsklinikum Würzburg, Jena University Hospital, Ludwig-Maximilians-Universität München, University Medical Center Freiburg, TUM Klinikum, Technical University of Munich, University of Würzburg, Comprehensive Cancer Center Mainfranken

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564000840

FWCI: 4.857

Cites: 25

Cited by: 48

Related to: 10